文献速递急性肾损伤肾血管病与高血压

肾脏体积预测并修饰RAS抑制剂相关急性肾损伤

Kidney Volume as a Predictor and Modifier of Acute Kidney Injury with Renin-Angiotensin System Inhibitors.
PubMed 文献 · Clin J Am Soc Nephrol · 2025-11-26

本研究通过回顾性队列和横断面研究,探讨肾脏体积作为肾单位数量替代标志物在心血管手术后急性肾损伤(AKI)预测中的作用。发现较低的身高调整总肾体积(htTKV)与术后AKI独立相关,且RAS抑制剂仅在htTKV低于100 ml/m²的患者中显著增加AKI发生率。肾活检显示htTKV≤100 ml/m²与肾小球硬化比例更高相关。

要点

  • 低htTKV是心血管手术后AKI的独立危险因素(OR 1.48每SD降低)。
  • RAS抑制剂仅在htTKV<100 ml/m²时显著增加术后AKI发生率。
  • htTKV≤100 ml/m²与肾小球硬化比例更高独立相关。

核心结论

  • 低htTKV与心血管手术后AKI风险增加独立相关,且RAS抑制剂的使用仅在低htTKV患者中与更高的AKI发生率相关。
  • 推测RAS激活可能通过肾小球高滤过维持低htTKV患者的eGFR,而RAS抑制剂可能削弱这种代偿机制导致AKI。

研究设计与样本

  • 单中心回顾性队列研究纳入2012-2020年接受心血管手术的成人(≥18岁)518例。
  • 横断面研究纳入2014-2023年接受肾活检的成人136例,诊断为IgA肾病、肾硬化或轻微肾小球异常。
  • htTKV通过SYNAPSE VINCENT图像分析系统测量。

主要发现

  • 518例心血管手术患者中177例发生AKI。
  • 较低htTKV和较高eGFR/TKV(而非较大年龄)与AKI独立相关(OR 1.48;95%CI 1.05-1.92,htTKV每降低1个标准差)。
  • RAS抑制剂使用与AKI发生率显著升高相关,仅在htTKV<100 ml/m²时(交互作用P=0.001)。
  • 136例肾活检患者中,htTKV≤100 ml/m²与肾小球硬化比例更高独立相关。

关键数值与推荐

  • htTKV阈值100 ml/m²用于识别RAS抑制剂相关AKI风险增高的人群(交互作用P=0.001)。
  • htTKV每降低1个标准差,AKI风险OR为1.48(95%CI 1.05-1.92)。

临床怎么用

  • 对于htTKV≤100 ml/m²的患者,心血管手术前可能考虑暂停RAS抑制剂以预防AKI。
  • htTKV可作为肾单位数量的替代标志物,辅助评估术后AKI风险。

局限性

  • 单中心回顾性研究设计。
  • 样本量有限(队列518例,横断面136例)。
  • htTKV测量依赖于图像分析系统,可能存在测量偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: Small kidney volume was associated with a higher proportion of glomerulosclerosis independent of eGFR. Renin-angiotensin system inhibitors were associated with a higher incidence of AKI after cardiovascular surgery only among those with small kidney volume. Small kidneys for GFR may represent less viable nephrons and compensatory hyperfiltration. BACKGROUND: Reduced nephron number has been reported to be an independent risk factor for AKI. We aimed to investigate the clinical implications of kidney volume or age as a candidate surrogate marker of nephron number in predicting AKI after cardiovascular (CV) surgery. METHODS: A single-center retrospective cohort study and a cross-sectional study were conducted. The cohort study enrolled adults (age 18 years or older) who underwent CV surgery from 2012 to 2020 at a university hospital. The association of height-adjusted total kidney volume (htTKV) with postoperative AKI and an effect modification by htTKV for the association of renin-angiotensin system inhibitors (RASi) with AKI were assessed by logistic regression analyses. HtTKV was measured by the SYNAPSE VINCENT image analysis system. The cross-sectional study enrolled adults who underwent kidney biopsy from 2014 to 2023, with diagnoses of IgA nephropathy, nephrosclerosis, or minor glomerular abnormalities. The associations of htTKV with histopathological lesions were examined. RESULTS: Among 518 participants who underwent CV surgery, 177 developed AKI. Lower htTKV and higher eGFR per TKV, but not older age, were associated with AKI independent of eGFR (odds ratio of 1.48; 95% confidence interval, 1.05 to 1.92 per one-SD decrement of htTKV). The use of RASi was associated with a significantly higher incidence of AKI at htTKV lower than 100 ml/m 2 ( P for interaction 0.001). Such effect modification was not found for age. Among 136 participants with kidney biopsies, htTKV of 100 ml/m 2 or less was associated with a higher proportion of glomerular sclerosis independent of eGFR. CONCLUSIONS: We speculate that RAS activation might maintain eGFR by glomerular hyperfiltration in patients with low htTKV. Observed higher incidence of postoperative AKI among RASi users with smaller htTKV for eGFR supports this hypothesis. Withholding RASi before CV surgery might prevent AKI among those with htTKV of 100 ml/m 2 or less.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Kasugai T, Murashima M, Tomonari T, et al. Kidney Volume as a Predictor and Modifier of Acute Kidney Injury with Renin-Angiotensin System Inhibitors. Clin J Am Soc Nephrol. 2025. PMID: 41405467. doi:10.2215/CJN.0000000911

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。